Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
Showing 1,141 - 1,160 results of 21,342 for search '(( significant based decrease ) OR ( significant decrease decrease ))', query time: 0.44s Refine Results
  1. 1141
    Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by flow cytometry.

    Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by flow cytometry. by Alejandra Barrera-Rosales (21656278)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1142
    Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual).

    Combined illusion score index across conditions (NI: Non-Illusion; NIT: Non-Illusion Tactile; MS: Multisensory; UV: Unimodal Visual). by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1143
    Fig 6 -

    Fig 6 - by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1144
    Fig 5 -

    Fig 5 - by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1145
    Fig 4 -

    Fig 4 - by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1146
    Schematic of augmented reality system with tactile stimulator.

    Schematic of augmented reality system with tactile stimulator. by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1147
    Infographic of experimental conditions.

    Infographic of experimental conditions. by Kirralise J. Hansford (20670869)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1148
    Summary of the screened symptoms at baseline (t0) for completers (n = 160).

    Summary of the screened symptoms at baseline (t0) for completers (n = 160). by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1149
    Summary of the program evaluation.

    Summary of the program evaluation. by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1150
    Changes in continuous sleep measures from pre (t1) to post (t2) intervention.

    Changes in continuous sleep measures from pre (t1) to post (t2) intervention. by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1151
    Overview over the contents of the app program divided by level [28].

    Overview over the contents of the app program divided by level [28]. by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1152
    Sociodemographic information, participant flow, engagement, and compliance.

    Sociodemographic information, participant flow, engagement, and compliance. by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1153
    Changes in mental health symptoms after the sleep intervention (n = 160 completers).

    Changes in mental health symptoms after the sleep intervention (n = 160 completers). by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1154
    ‘Sleep2Ukraine’ study design.

    ‘Sleep2Ukraine’ study design. by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1155
    Density differences between pre- and post-measurements for program completers (N = 160).

    Density differences between pre- and post-measurements for program completers (N = 160). by Anton Kurapov (11346019)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1156
    Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose.

    Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1157
    Principal Component Analysis (PCA) to illustrate the distribution of the significant lipid metabolites among the groups (NL, SS and MASH).

    Principal Component Analysis (PCA) to illustrate the distribution of the significant lipid metabolites among the groups (NL, SS and MASH). by Laia Bertran (3685147)

    Published 2025
    Save to List
    Saved in:
  18. 1158
    Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results).

    Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results). by Duc Tran Quang (20564967)

    Published 2025
    Save to List
    Saved in:
  19. 1159
    Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results).

    Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, <sup>ns</sup> Non-significant results). by Duc Tran Quang (20564967)

    Published 2025
    Save to List
    Saved in:
  20. 1160
    Multi-strain model fitting based on data for influenza A and B cases from the 40th week of 2023 to the 17th week of 2024 in the United States.

    Multi-strain model fitting based on data for influenza A and B cases from the 40th week of 2023 to the 17th week of 2024 in the United States. by Shuanglin Jing (11886368)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: